<DOC>
	<DOCNO>NCT00040053</DOCNO>
	<brief_summary>The purpose study assess ondansetron treatment methamphetamine dependence .</brief_summary>
	<brief_title>Ondansetron Treatment Methamphetamine Dependence - 1</brief_title>
	<detailed_description>This study design preliminary assessment efficacy safety 3-wide range dos ondansetron ( 0.25 , 1.0 4.0 mg take orally twice per day ) reduce methamphetamine use subject methamphetamine dependence determine optimal dose ondansetron .</detailed_description>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>18 year age . Treatment seek meth dependence . Please contact site director detail .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>amphetamine dependence</keyword>
</DOC>